Mumbai, Aug. 12 -- Shilpa Medicare announced that its wholly-owned material subsidiary, Shilpa Pharma Lifesciences, has fully redeemed its outstanding senior, secured, rated, unlisted, and redeemable Non-Convertible Debentures (NCDs) on 11 August 2025.

Accordingly, there are no outstanding NCDs as on date with Shilpa Pharma Lifesciences.

Published by HT Digital Content Services with permission from Capital Market....